Raquel Pascual-Serra

Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance

R. Sánchez-Prieto, A. Vazquez, S. Sabater, 2015, Oncotarget.

p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story

R. Sánchez-Prieto, O. Roche, F. J. Cimas, 2016, Front. Cell Dev. Biol..

P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy.

R. Sánchez-Prieto, S. Sabater, M. Ruiz-Hidalgo, 2019, Cancer letters.

Blockage of autophagic flux is associated with lymphocytosis and higher percentage of tumoral cells in chronic lymphocytic leukemia of B cells

R. Sánchez-Prieto, F. Ruiz-Marcos, M. Ruiz-Hidalgo, 2019, Clinical and Translational Oncology.

ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology

A. Esparís-Ogando, A. Pandiella, L. del Peso, 2022, Cancers.

ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology

J. Encinar, R. Sánchez-Prieto, I. Sánchez-Pérez, 2021, Journal of cellular and molecular medicine.

p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models.

G. Bossi, R. Sánchez-Prieto, S. Sabater, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion

R. Sánchez-Prieto, J. M. Giménez-Bachs, M. Ruiz-Hidalgo, 2018, PloS one.